Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Frontiers in Endocrinology|July 15, 2022
Latent Autoimmune Diabetes in Adults and Metabolic Syndrome-A Mini ReviewNiansi Pan, Shimei Yang, Xiaohong Niu
Bioengineered|February 15, 2022
Liraglutide inhibits receptor for advanced glycation end products (RAGE)/reduced form of nicotinamide-adenine dinucleotide phosphate (NAPDH) signaling to ameliorate non-alcoholic fatty liver disease (NAFLD) in vivo and vitroJingquan Ji, Ming Feng, Yan Huang, et al.
Archives of Osteoporosis|April 28, 2023
The correlation between circulating growth differentiation factor 11 and the risk of osteopenia/osteoporosis in menMiaomiao Jin, Renjun Cao, Xiaohong Niu, et al.
Zhonghua Nei Ke Za Zhi|July 23, 2002
[The effects of complete Freund's adjuvant on prevention of pancrentitis and diabetes mellitus in non-obese diabetic mice]Xiaohong Niu, Zhiguang Zhou, Tiejian Jiang, et al.
Current Diabetes Reviews|September 13, 2018
Association of PPARG Gene Polymorphisms Pro12Ala with Type 2 Diabetes Mellitus: A Meta-analysisJunyan Li, Xiaohong Niu, JianBo Li, et al.
Scientific Reports|November 2, 2021
Genetic and physical interactions between Polη and Rev1 in response to UV-induced DNA damage in mammalian cellsTonghui Bi, Xiaohong Niu, Chunping Qin, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|September 7, 2010
[Expression changes of age-related genes in different aging stages of Caenorhabiditis elegans and the regulating effects of Chuanxiong extract]Xiaoyan Wang, Xiangming Wang, Danqiao Wang, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|July 13, 2010
[Effect of Ligusticum chuanxiong extract on lifespan of Caenorhabditis elegans and its underlying molecular mechanisms]Xiaoyan Wang, Xiangming Wang, Danqiao Wang, et al.
Cell Cycle (Georgetown, Tex.)|October 19, 2016
PCNA-Ub polyubiquitination inhibits cell proliferation and induces cell-cycle checkpointsZhoushuai Qin, Zhiqiang Bai, Ying Sun, et al.
Bioengineered|October 20, 2021
Liraglutide blocks the proliferation, migration and phenotypic switching of Homocysteine (Hcy)-induced vascular smooth muscle cells (VSMCs) by suppressing proprotein convertase subtilisin kexin9 (PCSK9)/ low-density lipoprotein receptor (LDLR)Jingquan Ji, Ming Feng, Xiaohong Niu, et al.
Pageof 5